Taltz 80 MG/ML autoinjectorml
Ended Awarded Last action
- Contract number
- SPE2DR26F4E8Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,279
Award facts
- Contract value 100% obligated
- $26,279.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $26,279.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML AutoInjector, with an ultimate completion date of January 13, 2026. This non-set-aside contract was awarded competitively on January 12, 2026, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The award is a child order under AmerisourceBergen's parent company, Cencora, Inc., which operates the pharmaceutical distribution and healthcare supply operations serving federal government agencies.
This delivery order is issued under Cencora's broader Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2031. This comprehensive IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The current award for TALTZ (ixekizumab), a biologic immunosuppressant commonly used for inflammatory conditions, represents a routine task order fulfillment within this broader contracting vehicle supporting the Defense Health Agency and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F4E8Q?
SPE2DR26F4E8Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F4E8Q worth?
The government has obligated $26,279 on SPE2DR26F4E8Q.
Is contract SPE2DR26F4E8Q an order under another contract?
Yes. SPE2DR26F4E8Q is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4E8Q competed?
The extent of competition for SPE2DR26F4E8Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award